Home » BIOWORLD'S STOCK CONTEST PICKS

BIOWORLD'S STOCK CONTEST PICKS

Jan. 4, 1991

Investment

David BlechBiotechnology General

Richard A. BockHana BiologicsBiotechnology GeneralCambridge Biotech

Nova Pharmaceuticals

Robert A. FildesAmgenGenetics InstituteCetusSynergenApplied Biosystems

Denise GilbertAmgenGenzyme

Jim McCamantCalgeneXomaCalifornia BiotechCytogen

BioWorld Dart TosserGreenwich PharmaceuticalCelgeneImmunexTransgenic Sciences

(c) 1997 American Health Consultants. All rights reserved.

Article reprints

BioWorld MedTech

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 10, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 10, 2024.
Newron hails ‘groundbreaking’ evenamide data in schizophrenia
BioWorld
Newron Pharmaceuticals SpA added heft to the data supporting evenamide, reporting positive top-line results from a phase II/III placebo-controlled trial of the...
UK industry prepping for fallout of US Biosecure Act
BioWorld
The industry in the U.K. is starting to get concerned about the U.S. Biosecure Act and the possible impact on its ability to use Chinese service providers, and...
Astrazeneca patents new CX3CR1 antagonists for heart failure
BioWorld Science
Astrazeneca AB has disclosed CX3C chemokine receptor 1 (CX3CR1; CMKBRL1; GPR13) antagonists reported to be useful for the treatment of heart failure, among others.

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.